Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Last month we shared the story of Jason Stanley, an Auburn University student who sustained a traumatic brain injury (TBI)when three other men ambushed and maliciously attacked him in an alleyway. Jason lost consciousness after falling and hitting his head on the concrete pavement, yet one of the assailants continued to kick him in the face, according to a witness. The attack left Jason with a spectrum of physical and psychological problems – a fractured skull, severed nerves, loss of hearing, dizziness, anxiety, confusion, anger, depression – all symptoms of a TBI that took doctors days to discover.

Read the rest of this entry »

The FDA recently issued a notice to critical health care professionals warning of the risk of serious bleeding events and mortality in patients who received Xigris, a medication approved by the FDA for the treatment of adult high-risk severe sepsis. Sepsis is a common, deadly and underdiagnosed disease that can develop as a complication after illnesses such as pneumonia and bacterial infections. High-risk sepsis is sepsis associated with acute organ dysfunction. Xigris is indicated when cardiovascular, renal or respiratory dysfunction occurs with severe sepsis.

Read the rest of this entry »